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Abstract.  Thrombospondin is a 420,000-D glycopro- 
tein that has recently been shown to have several prop- 
erties in common with the members of a class of 
adhesive proteins.  To characterize  further the adhesive 
properties of thrombospondin,  we have studied its 
ability to support cell attachment.  Thrombospondin 
adsorbed to plastic dishes supports the attachment of 
human endothelial and smooth muscle cells and the 
monocyte-like cell line (U937) as well as normal rat 
kidney cells. The majority of attached cells do not 
spread on the solid-phase thrombospondin.  The attach- 
ment of all four cell types to thrombospondin is abol- 
ished if the assay is performed in the presence of 
EGTA, although the cells still attach to fibronectin.  If 
thrombospondin is adsorbed to the dishes in the pres- 
ence of EGTA and then washed with buffer containing 
calcium before addition of the cells, attachment is still 
markedly inhibited,  indicating that calcium affects the 
conformation and function of thrombospondin.  Attach- 
ment of all four cell types is also markedly inhibited 
by the synthetic peptides gly-arg-gly-asp-ser-pro (GRG- 
DSP) and gly-arg-gly-asp-ala-cys (GRGDAC) but not 
by the control peptide gly-arg-gly-glu-ser-pro (GRG- 
ESP).  Affinity chromatography of n-octylglucoside ex- 
tracts of surface-labeled endothelial cells or smooth 
muscle cells on thrombospondin-Sepharose  and GRG- 
DSP-Affigel columns was used to identify an integrin 
complex related to glycoprotein IIb-IIIa as an RGD- 
dependent receptor for thrombospondin.  In addition,  a 
monoclonal antibody (LM609) that blocks attachment 
of endothelial cells to vitronectin,  fibrinogen,  and von 
Willebrand factor also inhibits attachment of en- 
dothelial cells to thrombospondin.  These data indicate 
that the attachment of cells to thrombospondin is 
mediated by RGD and calcium-dependent mechanisms 
and is conistent with the hypothesis that the GRGDAC 
sequence in thrombospondin is a  site for interaction 
with an integrin receptor of the 133 subclass. 
T 
HROMBOSPONDIN is a high  molecular weight glyco- 
protein  that  is  synthesized  and  secreted by various 
cells in culture (see Lawler, 1986 for a review). Throm- 
bospondin is also secreted by blood platelets at the site of vas- 
cular damage (Lawler,  1986). In terms of its structure  and 
functions,  thrombospondin is similar to the members of the 
class of adhesive proteins.  Our recent determination  of the 
amino acid sequence of thrombospondin revealed the pres- 
ence of the sequence arg-gly-asp-ala  (RGDA) in a region of 
the molecule designated  as the last type 3 repeat (Lawler 
and Hynes, 1986). The type 3 repeats are homologous with 
the calcium binding  sites of calmodulin and parvalbumin 
(Lawler  and  Hynes,  1986).  Thrombospondin  has  been 
shown to bind calcium by a cooperative mechanism  with an 
apparent  dissociation  constant  of 120 l.tM (Lawler and Si- 
mons,  1983). In addition,  a higher affinity (0.1 gM) interac- 
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tion can be detected with monoclonal antibodies (Dixit et al., 
1986). The binding of calcium to thrombospondin results in 
a  profound  conformational  change  (Lawler  and  Simons, 
1983; Lawler et al., 1985; Galvin et al., 1985; Dixit et al., 
1986).  The localization  of this  conformational  change,  by 
electron microscopy, agrees well with the location of the type 
3 repeats based on amino acid sequence data (Lawler et al., 
1985; Galvin et al.,  1985; Lawler and Hynes, 1986; Dixit 
et al.,  1986). 
The RGD sequence has been shown to be present in the 
members of a class of adhesive proteins that mediate cell at- 
tachment  (see Ruoslahti  and Pierschbacher,  1986 for a re- 
view).  A  family  of cell  surface receptor complexes,  des- 
ignated  integrins,  has been identified  which bind proteins 
containing  this  sequence (see Hynes,  1987, and Ruoslahti 
and Pierschbacher,  1987 for reviews). Cell attachment medi- 
ated  by  the  integrin  family  of  receptors  is  frequently 
specifically inhibited by synthetic peptides which include the 
RGD  sequence  (Pierschbacher  and  Ruoslahti,  1984a,b; 
Yamada and Kennedy,  1984; Ruoslahti  and Pierschbacher, 
1986). The integrins are composed of a  and 13 subunits that 
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three distinct 13 subunits each of which can associate with 
several  different ¢t subunits (Hynes, 1987; Ginsberg et al., 
1988;  Phillips et al.,  1988).  The members of the 133 or cy- 
toadhesin subfamily have the same 13  subunit, designated 
integrin 133 or GPIIIa. At least two distinct ¢t subunits that 
associate with the integrin 133 subunit have been identified to 
date. The vitronectin receptor tx subunit is present on MG63 
osteosarcoma cells (Pytela et al., 1986). When this receptor 
is purified and incorporated into liposomes, the liposomes 
bind specifically to vitronectin. GPIIb is another ¢t subunit 
that associates with GPIIIa and is found exclusively on plate- 
let membranes (Ginsberg et al., 1988; Suzuki et al., 1987). 
The GPIIb-IIIa complex is capable of interacting with fibrin- 
ogen,  fibronectin, vitronectin, and von Willebrand factor 
(Plow et al., 1984,  1985, 1987). These two ct subunits of ttie 
133 subfamily are highly homologous at the amino acid se- 
quence level  (Fitzgerald et al.,  1987; Poncz et al.,  1987). 
They are each composed of a heavy chain with an apparent 
molecular mass of 125,000-130,000  D and a light chain with 
a molecular mass of 25,000  D (Phillips et al.,  1988). 
A GPIIb-IIIa-like integrin complex is found on the surface 
of many cell types, including endothelial cells, smooth mus- 
cle cells, and melanoma cells (Thiagarajan et al., 1985; Fitz- 
gerald et al.,  1985;  Leeksma et al.,  1986;  Newman et al., 
1986; Plow et al., 1986; Charo et al., 1986). The 13 subunit 
of this complex is also GPIIIa or integrin 133 (Ginsberg et 
al., 1987). Some of the antibody preparations that have been 
raised against GPIIb-IIIa also react with the GPIIb-IIIa-like 
molecules on endothelial cells and inhibit the attachment of 
endothelial cells to fibrinogen, vitronectin, and von Wille- 
brand factor (Charo et al., 1987; Cheresh, 1987; Chen et al., 
1987).  Thus,  in terms of ligand specificity,  the adhesion 
receptor on endothelial cells is similar to platelet GPIIb-IIIa 
in that it can interact with fibrinogen, von Willebrand factor, 
and vitronectin. 
Several lines of investigation have demonstrated that throm- 
bospondin is capable of interacting with cell surfaces. Throm- 
bospondin binds to a  low number of receptors  in resting 
platelets (Wolff  et al., 1986). After thrombin treatment of the 
platelets, a  10-fold increase in the number of receptor sites 
is observed (Wolff et al.,  1986).  Maximal binding activity 
is observed in the presence of calcium (Wolff et al.,  1986; 
Aiken et al.,  1987).  Thrombospondin has also been shown 
to bind to mouse peritoneal macrophages and to cells of the 
monocyte-like human cell line U937 (Silverstein and Nach- 
man,  1987).  The binding of thrombospondin to these cell 
types is divalent cation-dependent (Silverstein and Nach- 
man, 1987).  Recently, an 88,000-D membrane glycoprotein 
that is present in platelets, endothelial cells, monocytes, and 
several human tumor cell lines has been reported to function 
as a receptor for thrombospondin (Asch et al.,  1987). 
Platelet thrombospondin has been reported to support at- 
tachment of human squamous carcinoma cells, human mela- 
noma cells, human platelets, human fibroblasts,  bovine en- 
dothelial cells, and porcine epithelial cells (Varani  et al., 
1986;  Roberts et al.,  1987; Tuszynski et al.,  1987).  Cell 
spreading on the thrombospondin substrates varies consider- 
ably for the various cell types and lines (Varani et al., 1986; 
Roberts et al., 1987; Tuszynski et al., 1987).  Human G361 
melanoma cells spread on thrombospondin substrates (Ro- 
berts et al., 1987).  Roberts et al. (1987) have found that the 
heparin-binding domain must be present for thrombospon- 
din to support spreading. By contrast, the 18,000-D COOH- 
terminal portion of the molecule has been found to be essen- 
tial for cell attachment (Roberts et al., 1987). In this paper, 
we report that thrombospondin supports attachment of hu- 
man endothelial cells, human smooth muscle cells, human 
U937  cells,  and normal rat kidney (NRK) t cells by RGD 
and calcium-dependent mechanisms. In addition, the glyco- 
protein  IIb-IIIa-like  molecules  on  endothelial  cells  and 
smooth muscle cells are identified as a receptor for RGD- 
dependent binding of thrombospondin. 
Materials and Methods 
Preparation of  Protein Substrates 
Human platelet thrombospondin and human plasma fibronectin were puri- 
fied and iodinated as described previously (Engvall and Ruoslahti,  1977; 
Lawler et al.,  1985).  Human vitronectin was obtained from Calbiochem- 
Behring Corp.  (La Jolla,  CA) and human fibrinogen was obtained from 
Kabi Vitrnm (Stockholm, Sweden). BSA (Sigma RIA grade) was dissolved 
in 10 mM Hepes (pH 7.2), 135 mM NaCl, 3 mM KCI, and 0.5 mM MgC12 
(HBS) at a concentration of 2 mg/ml and heated to 70°C for 1 h. After heat 
treatment, 1 mM CaC12 or 0.5 mM EGTA was added to the BSA solutions. 
The synthetic polypeptides GRGDSE GRGESE and GRGDAC  were ob- 
tained from Peninsula Laboratories Inc. (Belmont, CA). 
Thrombospondin, fibronectin, vitronectin, or fibrinogen were diluted to 
20-40 I.tg/ml in HBS containing either 1 mM CaCl2 or 0.5 mM EGTA and 
adsorbed to the surface of 35-ram dishes (No.  1008; Falcon Labware, Ox- 
nard, CA) at 37°C for 2 h. To determine the amount of  thrombospondin that 
is adsorbed to the surface of the dishes, thrombospondin was radiolabeled 
with ~25I-Bolton-Hunter  reagent using protocols that are provided by the 
supplier (DuPont Co., Wilmington, DE). A thrombospondin concentration 
of 0.02 mg/ml resulted in the adsorption of 1.4 +  0.3 I.tg/cm  2 in either the 
presence of 1 mM CaCI2 or 0.5 mM EGTA. 
After protein adsorption, the dishes were washed three times with 3 ml 
of HBS containing either 1 mM CaCI2 or 0.5 mM EGTA and  1.5 ml of 
HBS containing 2 mg/ml BSA, and either 1 mM CaCI2 or 0.5 mM EGTA 
were added.  Synthetic peptides were added at this point to some of the 
dishes. In some experiments, the proteins were incubated in the dishes at 
37°C for 2 h in the presence of  0.5 mM EGTA. The dishes were then washed 
twice in HBS containing 0.5 mM EGTA and then washed once in HBS con- 
taining 1 mM CaCI2 before addition of the cells. In some experiments, 1.5 
ml of HBS containing 1 mM CaClz and 2 mg/ml BSA were added to the 
thrombospondin-coated dishes and then 2.25 ml of HBS, preiummune or 
anti-thrombospondin antibodies (0.6-0.8  mg/ml) were incubated overnight 
at 4°C in the dishes. The preimmune and anti-human platetet thrombospon- 
din antisera were fractionated by protein A-Sepharose affinity chromatogra- 
phy as described previously (Lawler et al.,  1985).  After incubation, the 
dishes were emptied and  1.5 ml of HBS containing 1 mM CaCI2 and 2 
mg/ml BSA were added before the addition of 1.5 ml of cell suspension. 
Attachment Assay 
Human umbilical vein and arterial endothelial cells and human arterial 
smooth muscle cell were grown in culture as described previously (Wein- 
stein and Wenc,  1986).  Human U937  cells were kindly provided by Dr. 
Livingston Van der Water (Beth Israel Hospital, Boston, MA) and were grown 
in DME containing 4.5 g/liter glucose and 10% FCS. The NRK cells were 
grown in DME containing 4.5 g/liter glucose and 5 % FCS. The endothelial, 
smooth muscle and NRK cells were washed once with 5 ml of HBS and 
were removed form the flasks  with 5  ml of HBS containing 0.1  mg/ml 
TPCK-trypsin (Worthington Biochemical Corp., Freehold, NJ) at 37°C for 
5 rain with continuous agitation. The cell suspension was removed, mixed 
with 5 ml of FIBS containing 0.5 mg/ml soybean trypsin inhibitor (Sigma 
Chemical Co., St. Louis, MO) and centrifuged at 400 g for 5 min. The cells 
were washed three times in HBS containing 0.5 mg/rrd soybean trypsin in- 
hibitor and then resuspended in a volume of HBS to give a final cell count 
1. Abbreviation  used in this paper:  NRK, normal rat kidney. 
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were harvested by centrifugation at 400 g for 5 min followed by three washes 
in HBS. The cell suspension (1.5 ml) was added to each protein-coated dish 
and the dishes were incubated at 37°C for 2 h. After incubation, the dishes 
were washed three times with 3 ml of HBS alone or with HBS containing 
1 mM CaCI2 or 0.5  mM EGTA.  The cells were fixed with 3%  parafor- 
maldehyde, stained with Giemsa, and photographed. The number of cells 
bound was determined by counting representative areas of the photomicro- 
graph. 
To  determine the effect of the  monoclonal antibody  LM609  (kindly 
provided by Dr. David Cheresh, La Jolla Cancer Research Foundation, La 
Jolla,  CA) on attachment, endothelial cells were incubated with varying 
concentrations of antibody in a total volume of 200 ~tl at 4°C for 1 h. The 
antibody was purified from ascites by affinity chromatography on a column 
of protein A-Sepharose (Sigma Chemical Co.).  After the incubation, the 
cell suspension was centrifuged at 400 g  for 6  min. The cell pellet was 
resuspended in 1.5 ml of riBS and added to the protein-coated dishes which 
were then incubated at 37°C for 1 h, washed, and fixed as described above. 
A~nity Chromatography 
Endothelial  cells or  smooth muscle cells  in  four  100-mm  dishes were 
washed three times in PBS (with 1 mM CaC12 and 1 mM MgC12). The cell 
layers were then incubated with 0.5 ml of PBS containing 1 mCi u~I, 20 
p.g/ml  lactoperoxidase, and 0.1  Ulml glucose oxidase. The dishes were 
rocked continuously for  10 rain at 22°C. The iodination mixture was re- 
moved and the cell layers were washed three times with PBS containing 1 
mM Nal. The cell layers from all four dishes were solubilized with 1.0 ml 
of PBS containing 200 mM n-octylglucoside (Boehringer Mannhein Bio- 
chemicals, Indianapolis, IN). The extract was incubated at 0°C for 15 rain 
and then centrifuged for 15 rain at 3,000 g. The supernatant was decanted 
and applied to either a column (0.8  x  4 cm) of thrombospondin-Sepharose 
or a column (0.8  x  1 cm) of GRGDSPC-Affi-gel 10. After the sample had 
entered the columns, the flow was stopped for 1 h. The columns were eluted 
with 60 ml PBS containing 50 mM n-octylglucoside (buffer A), followed 
by 2.5  ml of buffer A  containing  1 mg/ml of the peptide GRGESE and 
finally 2.5 ml of buffer A containing 1 mg/ml of the peptide GRGDSP. 
Immunoprecipitation 
lmmunoprecipitation of the various fractions was performed as described 
by Marcantonio and Hynes (1988).  Protein A-purified monoclonal antibody 
LMI42 (kindly provided by Dr. David Cheresh) was coupted to Sepharose 
4B  following standard procedures suggested by the supplier (Pharmacia 
Fine Chemicals, Piscataway, NJ). 100 ktl of  the antibody-Sepharose suspen- 
sion ("~20 I11 of  packed beads) was mixed with 250-500 ttl of sample. After 
immunoprecipitation, the pellet was solubilized in sample buffer and was 
subjected to electrophoresis  on 3.5-10.0%  acrylamide gradient gels (Lawler 
et al.,  1985). 
Results 
Attachment of  CeUs to Thrombospondin 
Human endothelial cells,  smooth muscle cells,  and  U937 
cells, as well as NRK cells attach to thrombospondin which 
is  adsorbed  to  plastic  surfaces  in  the presence of 1  mM 
CaC12 (Figs.  1 and 3). The effect of varying the concentra- 
tion of thrombospondin used to coat the dishes was assayed 
with NRK cells.  The number of cells that attach increases 
as the concentration of the thrombospondin solution used to 
coat the dishes increases up to 25 ~tg/ml (data not shown). 
From 25 to 75  llg/ml the number of cells that attached re- 
mained  constant.  A  thrombospondin  concentration of 20 
~tg/ml was used for the remainder of the experiments de- 
scribed in this report. All four of the cell types studied fail 
to attach to heat-treated BSA (Fig. 1 b). Less than 5 % of the 
attached (anchorage-dependent) cells (endothelial,  smooth 
muscle, and NRK) spread on the thrombospondin substrate 
(Figs.  1-3). By contrast, the majority of the attached cells 
spread on fibronectin substrates, when 1 mM CaCI2 is pres- 
Figure  1.  Attachment of endothelial cells to  (a)  thrombospondin 
(TSP),  (b) BSA, or (c), fibronectin (FN). The dishes were coated 
with the various proteins (0.02  mg/ml)  in HBS containing  1 mM 
CaCI2  for 2  h  at 37°C.  Bar,  100  Ixm. 
ent (Figs.  1 and 2).  Preincubation of the thrombospondin- 
coated dishes with protein A-purified polyclonal anti-throm- 
bospondin antibodies reduced the number of attached endo- 
thelial, smooth muscle, or NRK cells to 20 +  6.4, 9.4 +  2.1, 
or 21  +  5.8% of control, respectively. Preincubation of the 
thrombospondin-coated dishes with the preimmune immu- 
noglobulin did not reduce the number of cells attached (99 
+  6 % of control averaged over the three cell types). U937 
cells contain immunoglobulin receptors and  could not be 
readily studied in this system (Fleit et al.,  1982). 
The Effect of  Calcium on the Attachment 
of  CeUs to Thrombospondin 
Since calcium modulates the structure of thrombospondin, 
the effect of calcium on the attachment of the four cell types 
Lawler et al.  Cell Attachment to Thrombospondin  2353 Figure 2. The effect of calcium on the attachment of smooth muscle cells to (a and c) thrombospondin  (TSP) and (b and d) fibronectin 
(FN).  The dishes were coated with protein (0.02 mg/ml) in HBS containing either  1 mM CaC12 (a and b) or 0.5 mM EGTA (c and d) 
for 2 h at 37°C. The dishes were washed three times with HBS containing either  1 mM CaCI2 (a and b) or 0.5 mM EGTA (c and d). 
BSA solution (2 mg/ml) prepared in HBS containing either  1 mM CaC12 (a and b) or 0.5 mM EGTA (c and d) was added before addition 
of the cells that were resuspended  in HBS. Bar,  100 ~tm. 
was investigated. When the thrombospondin is adsorbed to 
the dishes in the presence of 0.5 mM EGTA and the cell at- 
tachment assay is performed in the presence of 0.25  mM 
EGTA, the attachment of all four cell types is abolished (Fig. 
2).  Note that  divalent cations  are  present  in  this  system, 
which contains 0.25 mM Mg  ++. The loss of attachment ac- 
tivity is not due to an inability of thrombospondin to bind to 
the plastic surface in the presence of EGTA since an equiva- 
lent amount of radiolabeled thrombospondin bound to the 
dishes  in either  1 mM CaCI2 or 0.5  mM EGTA (data not 
shown).  Under these experimental conditions the cells are 
still capable of attaching to fibronectin, albeit at a decreased 
level (Fig.  2).  The percentage of cells that  spread on the 
fibronectin substrate is markedly reduced in the presence of 
EGTA. These data indicate that the effect of EGTA may be, 
at least in part, due to an effect on the cells. To distinguish 
the effect of calcium on the thrombospondin substrate from 
its effect on the cells, the thrombospondin was adsorbed to 
the dishes in the presence of 0.5 mM EGTA and then washed 
with buffer containing 1 mM CaC12 before the incubation of 
the ceils in the presence of 0.5 mM calcium. The attachment 
of endothelial  cells,  smooth muscle cells,  U937  cells,  and 
NRK cells to this substrate was reduced to 1.1  +  0.8,  11  + 
2, 0.4  +  0.7, and 20  +  3 % of control values, respectively 
(Fig.  3).  By contrast,  equivalent numbers of attached and 
spread NRK cells were observed on fibronectin substrates 
prepared in the presence of 1 mM CaCI2 or 0.5 mM EGTA, 
when the cells were added in the presence of 0.5 mM CaCI2 
(data not shown). Thus, some of the effect of calcium deple- 
tion is on the thrombospondin. 
The Effect of  Synthetic Peptides on the 
Attachment of  CeUs to Thrombospondin 
The hexapeptide GRGDSP inhibits the attachment of all four 
cell types to thrombospondin in a  dose-dependent manner 
(Figs. 4 and 5). At a concentration of 0.4 mM GRGDSP, the 
inhibition was >94 % for all the four cell types. By contrast, 
the synthetic peptide GRGESP had only a  small inhibitory 
effect at the highest concentration (0.4 mM) tested (Figs. 4 
and 5). 
Based on the thrombospondin sequence, the peptide GRG- 
DAC was synthesized and its effect on attachment of the four 
cell types to thrombospondin was determined. This peptide 
also  inhibited  attachment of all  four  cell  types to  throm- 
bospondin in a dose-dependent manner (Fig. 5). A concen- 
tration of 0.4 mM GRGDAC reduced the number of endo- 
thelial, smooth muscle, U937, or NRK cells, which attached 
to thrombospondin, to 15  +  7.3, 4.3  -I- 3.6, 1.7  +  1.0, or 27 
+  2% of control,  respectively. 
Identification of  a RGD-dependent Receptor 
To identify the  receptor for thrombospondin,  endothelial, 
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tachment of NRK (a, c, and e) and U937 
(b, d,  and f) cells to thrombospondin. 
The dishes were coated with thrombo- 
spondin (0.02 mg/ml) in HBS containing 
either 1 mM CaC12 (a and b) or 0.5 mM 
EGTA (c-f). The dishes  were washed 
three times in HBS containing either  1 
mM CaC12 (a and b) or 0.5 mM EGTA 
(c and d) as in Fig.  2.  Two additional 
dishes  (e and f) were washed twice in 
HBS containing 0.5 mM EGTA followed 
by one wash in HBS containing  1 mM 
CaC12.  BSA  solution  (2  mg/ml)  pre- 
pared in HBS containing either  1 mM 
CaCI2 (a, b, e, and f) or 0.5 mM EGTA 
(c and d) was added before addition of 
the cells that were resuspended in HBS. 
Bar, 200 Ixm. 
and smooth muscle cell membranes were radiolabeled with 
t25I-lactoperoxidase,  extracted with n-octylgucoside, and ap- 
plied to a column of thrombospondin-Sepharose.  Whereas 
most of the radiolabeled proteins flow through the column, 
two proteins with reduced molecular masses of 128,000  and 
100,000  D  are retarded by the column (Fig. 6).  Low levels 
of these proteins continue to be eluted from the column after 
20 bed volumes of buffer A. Fig. 6 shows the quantity of the 
100,000-D  protein  that  is  eluted  from  the  thrombospon- 
din-Sepharose  column  as  a  function  of  fraction  number 
when an endothelial  cell extract is applied.  A  peak in the 
quantities  of both  the  128,00-  and  100,000-D  proteins  is 
eluted with buffer A containing 1 mg/ml of the peptide GRG- 
DSP (Fig.  6).  SDS-PAGE of the eluted proteins in the ab- 
sence of reducing  agent reveals two bands with molecular 
masses of 140,000 and 85,000 D (Fig. 7). The amount of ra- 
dioactivity that was subjected to electrophoresis at the dye 
front is decreased in nonreduced samples suggesting that at 
least one of the high molecular mass bands is linked to a light 
chain by disulfide bonds. The polypeptides that are isolated 
from endothelial  cells and  smooth muscle cells comigrate 
(Fig. 8). The polypeptides isolated from endothelial cells on 
thrombospondin-Sepharose  are  similar  to  integrin  com- 
plexes that are isolated on GRGDSP-Sepharose (Cheresh, 
1987). To establish this identity we have (a) applied extracts 
of endothelial cells and smooth muscle cells to a column of 
GRGSPC-Affi-gel and (b) have performed immunoprecipi- 
tations with antibodies to a M21 melanoma cell integrin com- 
plex with similar electrophoretic properties (Cheresh,  1987). 
The polypeptides that are eluted from a GRGDSPC-Afli-gel 
column with 1 mg/ml GRGDSP comigrate with those eluted 
from the thrombospondin-Sepharose (Fig. 7).  In addition, 
the polypeptides that are eluted from the thrombospondin- 
Sepharose column, when either endothelial cell or smooth 
muscle cell extracts are applied to the column, can be immu- 
noprecipitated with monoclonal antibody LM142-Sepharose 
(Fig.  8).  This antibody is directed against the ct-subunit of 
an M21 melanoma cell integrin complex and has been shown 
to immunoprecipitate the GPIIb-IIIa-like  complex from hu- 
man endothelial cells (Cheresh,  1987). 
The Effect of  Monoclonal Antibody LM609 on 
Endothelial Ceil Attachment to Thrombospondin 
Monoclonal antibody LM609 also reacts with the integrin 
complex  that  is  present  on  M21  melanoma cells  and  en- 
dothelial cells (Cheresh,  1987).  Whereas antibody LM142 
does not inhibit attachment of endothelial cells to adhesive 
proteins, antibody LM609 specifically inhibits attachment of 
endothelial cells to vitronectin,  fibronogen, and yon Wille- 
brand factor (Cheresh,  1987).  A  dose-dependent inhibition 
of attachment of endothelial cells to thrombospondin is ob- 
served when the cells are preincubated with varying concen- 
trations of antibody LM609,  but not with antibody LM142 
(Fig. 9).  For comparison, the effect of antibody LM609 on 
Lawler et al.  Cell Attachment  to  Thrombospondin  2355 Figure 4. The effect of synthetic peptides on the attachment of (a, c, and e) smooth muscle cells (SMC) and (b, d, and f) U937 cells to 
thrombospondin.  The dishes were coated with thrombospondin  (0.2 mg/ml) dissolved in HBS containing  1 mM CaCI2. Before addition 
of the cells, either no peptide (a and b), 0.4 mM GRGDSP (c and d), or 0.4 mM GRGESP (e and f) was added to the dishes. Bar, 100 gm. 
attachment of endothelial cells to vitronectin and fibrinogen 
was also studied. The cellular attachment to vitronectin was 
inhibited by antibody LM609 to an extent that was quantita- 
tively equivalent to the  inhibition  of attachment to throm- 
bospondin (Fig. 9). By contrast, endothelial cell attachment 
to  fibrinogen  was  completely  abolished  by  the  antibody 
LM609 at all concentrations studied  (Fig.  9). 
Discussion 
The data presented show that thrombospondin can act as a 
cell attachment factor for a variety of cells. The attachment 
to  thrombospondin  of all  four  cell  types  included  in  this 
study is abolished if the thrombospondin is adsorbed to the 
dishes in the presence of EGTA and the cells are incubated 
in the dishes in the presence of EGTA. That is, attachment 
to thrombospondin is Ca++-dependent whereas attachment 
to fibronectin is not. If dishes coated with thrombospondin 
in the absence of Ca  ++ are washed with buffer containing  1 
mM CaC12 before the addition of the cells, the attachment 
activity is partially recovered (10-20%  of control) for the 
NRK and smooth muscle cells, but not for the endothelial 
or U937 cells (<2% of control). These results show that the 
major effect of Ca  ++ depletion  is on the  thrombospondin, 
not the cells, and indicate that, for the most part, the throm- 
bospondin that is adsorbed to the plastic in the presence of 
EGTA does not revert to the calcium-dependent form upon 
calcium restoration. The low level of attachment that is ob- 
served on restoration of calcium may be due to the ability of 
some of the thrombospondin molecules to recover or may be 
due to an effect on the cell surface receptors. In the latter 
case, a calcium-dependent increase in the receptor's affinity 
for thrombospondin may partially compensate for the fact 
that the conformation of the thrombospondin molecules is 
not correct. 
The data presented here also suggest that the GRGDAC se- 
quence of thrombospondin is the functional site for the at- 
tachment of the four cell types studied. This sequence occurs 
in  the  last  type 3  repeating  sequence  of thrombospondin 
(Lawler and Hynes,  1986;  Lawler and Hynes,  1987).  The 
sequences  of the  type 3  repeats are homologous with the 
calcium-binding sites of calmodulin and parvalbumin. The 
presence of the GRGDAC sequence in the calcium-binding 
region of thrombospondin is consistent with the observation 
that the attachment of cells to thrombospondin is calcium de- 
pendent. Calcium may be affecting the activity of the RGD 
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Figure 5.  The effect of synthetic  peptides  on the  attachment  to 
thrombospondin of smooth muscle cells,  U937 cells,  NRK cells, 
and endothelial cells. The dishes were coated with thrombospondin 
(0.02 mg/ml dissolved  in HBS containing 1 mM CaC12). Before 
addition of the ceils, either no peptide (0), 0.2 mM GRGDSP, 0.4 
mM GRGDSP, 0.2 mM GRGDAC, 0.4 mM GRGDAC, or 0.4 mM 
GRGESP was added to the dishes. 
sequence by altering the conformation of thrombospondin in 
two ways.  At the level of the whole molecule, the calcium- 
induced change in  the  orientation of the COOH-terminal 
globular domain may affect the exposure of the RGD site or 
may  affect the juxtaposition of other parts  of the throm- 
bospondin molecule that also participate in the interaction 
with cell surface receptors (Lawler et al.,  1985; Galvin et 
al.,  1985; Lawler and Hynes, 1987). On a local level, cal- 
cium may be required to form a loop structure that presents 
the RGD sequence in a conformation that is recognized by 
the receptor. 
We propose that the calcium-binding  sites of thrombospond- 
in  are loop structures based on their sequence homology 
with the calcium-binding  sites  of other proteins of estab- 
lished structure and based on secondary structural analysis 
using a predictive algorithm (Chou and Fasman, 1978; Kret- 
singer,  1980). A schematic diagram of the structure of the 
type 3 repeat which contains the RGD sequence is shown in 
Fig. 10. The or-helix and ~-sheet potentials, calculated using 
the Chou and Fasman (1978) algorithm, are low throughout 
the region. By contrast, the loop potential is high in this re- 
gion as indicated by the averages of the normalized frequen- 
cies of amino acid occurrence in omega loops (Leszczynski 
and Rose, 1986). A detailed algorithm for the prediction of 
loops has not been published to date. ~turns with relatively 
high probability are predicted at the beginning and end of the 
sequence shown in Fig.  l0 (Chou and Fasman,  1978).  The 
remainder of the sequence is proposed to form two loops 
around each calcium ion (Fig.  10). In this model the oxygen 
atoms of  the D residues at the octahedral vertices x, y, z, -x, 
and -z form the calcium-binding site as they do in parvalbu- 
min and related proteins (Kretsinger, 1980). There is one ad- 
ditional amino acid between the -x and  -z coordinates in 
the first loop.  A  similar  insertion occurs in  the calcium- 
binding site of the gamma-subunit of fibrinogen (Dang et al., 
Figure 6. Isolation of a throm- 
bospondin receptor from hu- 
man endothelial cells. Endo- 
thelial  cell  membranes  were 
radiolabeled  with  t25I-lacto- 
peroxidase, extracted with 200 
mM n-octylglucoside, and ap- 
plied to a column of thrombo- 
spondin-Sepharose.  The elu- 
tion of the column is described 
in Material and Methods. The 
quantity of  the 100,000-D  pro- 
tein was determined from den- 
sitometric scan of the autora- 
diograph.  The  initial  lanes 
could not be quantitated be- 
cause of  the high level of  back- 
ground  radioactivity. Note 
small increase in all of the ra- 
dioactive binds after fraction 
17  is  probably  due to a  de- 
crease in the flow rate that is 
done to conserve peptides. 
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with GRGDSP from thrombospondin-Sepharose  (TSP) 
or GRGDSPC-Affi-gel (RGD) columns, after applica- 
tion of extracts of endothelial cells (EC) or smooth 
muscle cells (SMC). The samples were subjected to 
electrophoresis in the absence (right) or presence (leJO 
of 1 mM DTT. The molecular masses of the principal 
bands are indicated in kilodaltons. 
1985). The second loop brings the two C residues into close 
proximity. We propose that these C residues form a disulfide 
bond which stabilizes the loop. 
In the model proposed in Fig. 10, the D residue of the RGD 
cell binding domain is one of the residues proposed to be in- 
volved in calcium binding.  Assuming that calcium does, in 
fact, bind to this residue,  there must be a  mechanism that 
enables the D  residue also to participate in the interaction 
with the cell surface receptor. This could be accomplished 
by a simple, competitive mechanism if the receptor affinity 
is high enough. Alternatively, it is possible that a calcium or 
magnesium ion also participates in the interaction with the 
cell  surface  receptor  such  that  a  calcium-binding  site  is 
formed by sequences from thrombospondin and its receptor. 
The  ct-subunits  of the  integrin  family of adhesive protein 
receptors have calcium-binding sites that are similar in terms 
of amino acid sequence to those found in thrombospondin 
(Fitzgerald et al.,  1987;  Suzuki et al.,  1987;  Poncz et al., 
1987). 
The location of the RGD sequence within the type 3 repeat 
may have some implications for its evolutionary origin in 
thrombospondin.  The  RGD  sequence  occurs  at  positions 
12-14 within the repeat (Lawler and Hynes, 1986). The GD 
sequence occurs at positions  13 and  14 of all of the type 3 
repeats, suggesting that these residues are important for cal- 
cium binding.  The 12 position is occupied by five different 
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Figure 10. Schematic model of 
the  RGD cell-binding  region 
of thrombospondin. The com- 
plete amino acid sequence of 
the last type 3 repeat (N[897] 
-V[932]) is shown. The pro- 
posed coordinates (x, y, z, -x, 
and  -z) for calcium  binding 
based on other calcium-bind- 
ing proteins and the nomencla- 
ture of Kretsinger (10) are in- 
dicated. 
Figure  8.  Immunoprecipitation  of eluted  proteins  with  LM142- 
Sepharose.  The proteins that were eluted from the thrombospon- 
din-Sepharose column after application of endothelial cell (a and 
c) or smooth muscle cell (b and d) extracts were immunoprecipi- 
tated with LM142-Sepharose.  The samples were subjected to elec- 
trophoresis in the absence (right) and presence (left) of 1 mM DTT. 
The molecular masses of the principal bands are indicated in kilo- 
daltons. 
amino acids, suggesting that this position can vary without 
loss  of calcium-binding  activity.  We  hypothesize that  the 
seven type 3 repeats were formed by a series of endoduplica- 
tions of a  primordial gene that encoded a  calcium-binding 
motif. The amino acids that were not specifically involved 
in calcium binding were free to diverge. When an R residue 
arose in position 12 of the last type 3 repeat, thrombospondin 
obtained the ability to intract with cell surfaces via an exist- 
ing family of receptors. 
_~ lO0~a,~ 
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Figure 9. The effect of antibody 
LM609 in attachment of endo- 
thelial cells to thrombospondin 
(o),  vitronectin  (e),  and  fi- 
brinogen (~2). The dishes were 
coated with 0.02 mg/ml of pro- 
tein dissolved in HBS contain- 
ing 1 mM CaCI2. For throm- 
bospondin,  each point  is the 
average of 12 determinations 
with an average  standard devia- 
tion of 20%.  For vitronectin, 
each  point  is  the  average of 
seven determinations  with an 
average standard deviation of 
17 %.  For fibrinogen,  attach- 
ment  was  completely  abol- 
ished. 
The data presented here indicate that the GPIIb-IIIa-like 
complex on the surface of endothelial and smooth muscle 
cells functions  as an  RGD-dependent receptor for throm- 
bospondin. These results and the data of Cheresh (1987) sug- 
gest that thrombospondin, vitronectin,  fibrinogen, and von 
WiUebrand factor interact with a common integrin receptor 
on endothelial cells.  However, this conclusion needs to be 
forwarded with caution.  Since the members of the 133 sub- 
family are very similar to each other and share a  common 
I~ subunit, it is common for antibodies that have been raised 
against one member to cross react with other members of 
the  subfamily. Antibodies that were raised against platelet 
GPIIb-IIIa  inhibit the binding of thrombospondin to platelets 
(Plow et al.,  1985).  However, thrombasthenic platelets bind 
normal levels of thrombospondin (Aiken et al.,  1986). This 
raises the possibility that the vitronectin, thrombospondin, 
fibrinogen, and von Willebrand receptors are similar but dis- 
tinct entities. The monoclonal antibody LM609 reacts with 
the 133 integrin complex found on endothelial cells,  smooth 
muscle cells, and melanoma cells (Cheresh,  1987;  Cheresh 
and Spiro, 1987). This antibody does not immunoprecipitate 
the GPIIb-IIIa  complex on platelets or the vitronectin recep- 
tor on MG63 osteosarcoma cells (Cheresh,  1987;  Cheresh 
and Spiro,  1987). 
Whereas the data presented here are consistent with previ- 
ous studies in establishing that thrombospondin can support 
attachment of cells, most previous studies have not demon- 
strated an RGD effect (Varani et al.,  1986;  Roberts et al., 
1987;  Tuszynski et al.,  1987).  Santoro (1987) has reported 
that  the  attachment  of platelets  to  thrombospondin  is  in- 
hibited by an RGD-containing peptide. By contrast, Roberts 
et al. (1987)  have reported that GRGDSP did not inhibit the 
attachment and spreading of G361 melanoma cells to throm- 
bospondin. A possible explanation for the differential effects 
of GRGDSP is that the G361  melanoma cells are binding to 
thrombospondin by a  mechanism that is distinct  from the 
mechanism employed by the cell types included in this study. 
Thrombospondin has been shown to interact with cell sur- 
faces by several different mechanisms.  Globular regions at 
both the NH2- and COOH-terminal have been implicated in 
platelet aggregation or cell attachment and spreading (Law- 
ler,  1986;  Roberts et al.,  1987). 
A  cell surface receptor for thrombospondin has recently 
been  purified  from  C32  melanoma cells  and  platelets  by 
Asch et al. (1987).  The receptor is an 88,000-D glycoprotein 
and is apparently identical to platelet membrane glycopro- 
tein  IV  (GPIV).  The  interaction  of thrombospondin  with 
GPIV is inhibited by EGTA, as is cell attachment of the cell 
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the interaction with isolated GPIV is not inhibited by the syn- 
thetic peptide RGDS. Several hypotheses can be proposed to 
reconcile these data. The purification of GPIV may have in- 
duced a conformational change that has resulted in the loss 
of RGD specificity. Alternatively, another component of the 
membrane may bind to GPIV in much the same way GPIIb 
and GPIIIa  form a complex.  Such an additional component 
might  confer  RGD  specificity.  A  third possibility  is  that 
GPIV is not functioning as the receptor in cell attachment 
assays. GPIV has been isolated from C32 melanoma cells by 
immunoaffinity columns prepared with the monoclonal anti- 
body OKM5 (Asch et al.,  1987). Roberts et al. (1987) have 
reported that antibody OKM5 does not inhibit attachment of 
C32 melanoma cells to thrombospondin. 
The results presented here indicate that the RGD sequence 
of thrombospondin is active in supporting cell attachment. 
Furthermore, the ability of the RGD sequence to support at- 
tachment  is  dependent upon the preservation  of calcium- 
dependent structures in thrombospondin. Whereas divalent 
cations have been shown to be important to the interaction 
of adhesive proteins with the integrin family of cell surface 
receptors,  the divalent cations generally bind to the or-sub- 
units of these receptors. Thrombospondin represents the first 
example of divalent cation modulation of the RGD in the 
ligand. It is currently unclear how divalent cation concentra- 
tion could be regulated in an extracellular environment. One 
possibility  is  that glycosaminoglycans could bind divalent 
cations and affect  their local  concentration.  Alternatively, 
calcium  binding may  not be  a  regulatory  mechanism  for 
these proteins. The calcium ion may be a component of the 
native molecule that confers conformational stability or re- 
sistance to proteolysis. 
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